George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 526.00
Bid: 526.00
Ask: 527.00
Change: -3.00 (-0.57%)
Spread: 1.00 (0.19%)
Open: 530.00
High: 530.00
Low: 524.00
Prev. Close: 529.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

28 Sep 2023 17:36

RNS Number : 0672O
Polar Capital Holdings PLC
28 September 2023
 

28 September 2023

Polar Capital Holdings PLC (the "Company")

Result of AGM held on 28 September 2023

 

 

Legal Entity Identifier: 549300OXX7YE1947B825

Polar Capital Holdings plc is pleased to announce that all the resolutions proposed at its annual general meeting ("AGM") held at 2.00 pm on 28 September 2023 were passed on a poll including all valid proxies submitted prior to the meeting.

The following table indicates the number of votes cast by poll for each of the resolutions. The total issued share capital at the date of the meeting was 101,195,879 ordinary shares with voting rights of one vote per share. There were no shares held in Treasury. A total of 58,326,872 votes were lodged (including the withheld votes) on each of the undernoted resolutions. Votes withheld do not constitute votes in law and are not counted in the number of votes for or against any resolution.

Resolutions 14 and 15 had been passed as special resolutions. In accordance with section 30 of the Companies Act, copies of these resolutions will be submitted to Companies House for addition to the Company register. 

The full text and explanation of the business was provided in the Notice of Meeting which is available on the Company's website at: www.polarcapital.co.uk

 

 

Resolution

Shares For

(including discretionary)

%

Shares Against

%

Votes Withheld

1. To receive the Annual Report and Audited financial statements for the year ended 31 March 2023

58,193,893

100.00

440

0.00

132,539

2. To approve Directors' Remuneration Implementation Report for the year ended 31 March 2023

57,527,265

98.66

782,018

1.34

17,589

3. To re-elect Laura Ahto as a Director

57,951,123

99.82

105,417

0.18

270,332

4. To re-elect Anand Aithal as a Director

55,932,444

99.37

354,549

0.63

2,039,879

5. To re-elect Samir Ayub as a Director

58,244,836

99.93

39,761

0.07

42,275

6. To re-elect Alexa Coates as a Director

56,194,200

96.38

2,107,981

3.62

24,691

7 To re-elect David Lamb as a Director

58,214,172

99.84

92,368

0.16

20,332

8 To re-elect Win Robbins as a Director

58,006,630

99.49

298,060

0.51

22,182

9. To re-elect Gavin Rochussen as a Director

58,278,206

99.95

28,334

0.05

20,332

10. To re-elect Andrew Ross as a Director

58,213,919

99.84

92,523

0.16

20,430

11. To appoint PricewaterhouseCoopers LLP as Auditors

58,199,313

99.81

113,515

0.19

14,044

12. To authorise the Audit and Risk Committee to determine the auditors' remuneration

58,103,697

99.63

214,377

0.37

8,798

13. To allot shares

57,956,596

99.39

353,314

0.61

16,962

14. To disapply pre-emption rights

50,315,449

86.56

7,810,037

13.44

201,386

15. To authorise the Company to buy-back its own shares

58,134,854

99.98

14,510

0.02

177,508

 

 

 Enquiries:

 

Neil Taylor

Company Secretary

+44 (0)20 7227 2700

END

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKFBNABKDNCB
Date   Source Headline
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.